Albumin 白蛋白 | Conv. Units br>Female | ≥D1 : < D15 | 3.3 - 4.5 g/dL | ≥D15 : < Y1 | 2.8 - 4.7 g/dL | ≥Y1 : < Y8 | 3.8 - 4.7 g/dL | ≥Y8 : < Y15 | 4.1 - 4.8 g/dL | ≥Y15 : < Y19 | 4.0 - 4.9 g/dL | ≥Y19 | 3.5 - 5.0 g/dL | Male | ≥D1 : < D15 | 3.3 - 4.5 g/dL | ≥D15 : < Y1 | 2.8 - 4.7 g/dL | ≥Y1 : < Y8 | 3.8 - 4.7 g/dL | ≥Y8 : < Y15 | 4.1 - 4.8 g/dL | ≥Y15 : < Y19 | 4.1 - 5.1 g/dL | ≥Y19 | 3.5 - 5.0 g/dL | S.I. Units br>Female | ≥D1 : < D15 | 33 - 45 g/L | ≥D15 : < Y1 | 28 - 47 g/L | ≥Y1 : < Y8 | 38 - 47 g/L | ≥Y8 : < Y15 | 41 - 48 g/L | ≥Y15 : < Y19 | 40 - 49 g/L | ≥Y19 | 35 - 50 g/L | Male | ≥D1 : < D15 | 33 - 45 g/L | ≥D15 : < Y1 | 28 - 47 g/L | ≥Y1 : < Y8 | 38 - 47 g/L | ≥Y8 : < Y15 | 41 - 48 g/L | ≥Y15 : < Y19 | 41 - 51 g/L | ≥Y19 | 35 - 50 g/L |
|
Alkaline Phosphatase 鹼性磷酸酵素 | Conv. Units br>Female | ≥ D1 - < D15 | | 90-273 U/L | ≥ D15 - < Y1 | | 134-518 U/L | ≥ Y1 - < Y10 | | 156-369 U/L | ≥ Y10 - < Y13 | | 141-460 U/L | ≥ Y13 - < Y15 | | 62-280 U/L | ≥ Y15 - < Y17 | | 54-128 U/L | ≥ Y17 - < Y19 | | 48-95 U/L | ≥ Y19 - < Y30 | | 44-107 U/L | ≥ Y30 - ≤ Y99 | | 46-122 U/L | Male | ≥ D1 - < D15 | | 90-273 U/L | ≥ D15 - < Y1 | | 134-518 U/L | ≥ Y1 - < Y10 | | 156-369 U/L | ≥ Y10 - < Y13 | | 141-460 U/L | ≥ Y13 - < Y15 | | 127-517 U/L | ≥ Y15 - < Y17 | | 89-365 U/L | ≥ Y17 - < Y19 | | 59-164 U/L | ≥ Y19 - < Y22 | | 56-167 U/L | ≥ Y22 - ≤ Y99 | | 50-116 U/L | S.I. Units br>Female | ≥ D1 - < D15 | | 90-273 U/L | ≥ D15 - < Y1 | | 134-518 U/L | ≥ Y1 - < Y10 | | 156-369 U/L | ≥ Y10 - < Y13 | | 141-460 U/L | ≥ Y13 - < Y15 | | 62-280 U/L | ≥ Y15 - < Y17 | | 54-128 U/L | ≥ Y17 - < Y19 | | 48-95 U/L | ≥ Y19 - < Y30 | | 44-107 U/L | ≥ Y30 - ≤ Y99 | | 46-122 U/L | Male | ≥ D1- < D15 | | 90-273 U/L | ≥ D15 - < Y1 | | 134-518 U/L | ≥ Y1 - < Y10 | | 156-369 U/L | ≥ Y10 - < Y13 | | 141-460 U/L | ≥ Y13 - < Y15 | | 127-517 U/L | ≥ Y15 - < Y17 | | 89-365 U/L | ≥ Y17 - < Y19 | | 59-164 U/L | ≥ Y19 - < Y22 | | 56-167 U/L | ≥ Y22 - ≤ Y99 | | 50-116 U/L |
|
Alpha-Fetoprotein 甲種胚胎蛋白 | Conv. Units br>Healthy adults (97.5 %ile) | < 8.8 ng/mL | Healthy adults (99.5 %ile) | < 15.0 ng/mL | S.I. Units br>Healthy adults (97.5 %ile) | < 7.3 IU/mL | Healthy adults (99.5 %ile) | < 12.5 IU/mL |
|
Appearance 外觀 | N/A |
UMicro (Bacteria) 細菌 | N/A |
Basophils 嗜鹼細胞 | ≧D1 : < Y21 | | 0.3 - 1.2 % | ≧Y21 : ≦ Y150 | | 0.1 - 1.1 % |
|
Basophils 嗜鹼細胞 | ≧D1 : < Y21 | | 0.0 - 0.1 109/L | ≧Y21 : ≦ Y150 | | 0.0 - 0.1 109/L |
|
Bilirubin 膽紅素 | |
Bilirubin, Total 總膽紅素 | Conv. Units br>Female | ≥M1 : < Y1 | 0.1 - 0.7 mg/dL | ≥Y1 : < Y9 | 0.1 - 0.4 mg/dL | ≥Y9 : < Y12 | 0.1 - 0.6 mg/dL | ≥Y12 : < Y15 | 0.1 - 0.7 mg/dL | ≥Y15 : < Y19 | 0.1 - 0.8 mg/dL | ≥Y19 : ≤ Y99 | 0.3 - 1.2 mg/dL | Male | ≥M1 : < Y1 | 0.1 - 0.7 mg/dL | ≥Y1 : < Y9 | 0.1 - 0.4 mg/dL | ≥Y9 : < Y12 | 0.1 - 0.6 mg/dL | ≥Y12 : < Y15 | 0.1 - 0.7 mg/dL | ≥Y15 : < Y19 | 0.1 - 0.8 mg/dL | ≥Y19 : ≤ Y99 | 0.3 - 1.2 mg/dL | S.I. Units br>Female | ≥M1 : < Y1 | 1.7 - 12.0 umol/L | ≥Y1 : < Y9 | 1.7 - 6.8 umol/L | ≥Y9 : < Y12 | 1.7 - 10.3 umol/L | ≥Y12 : < Y15 | 1.7 - 12.0 umol/L | ≥Y15 : < Y19 | 1.7 - 13.7 umol/L | ≥Y19 : ≤ Y99 | 5.1 - 20.5 umol/L | Male | ≥M1 : < Y1 | 1.7 - 12.0 umol/L | ≥Y1 : < Y9 | 1.7 - 6.8 umol/L | ≥Y9 : < Y12 | 1.7 - 10.3 umol/L | ≥Y12 : < Y15 | 1.7 - 12.0 umol/L | ≥Y15 : < Y19 | 1.7 - 13.7 umol/L | ≥Y19 : ≤ Y99 | 5.1 - 20.5 umol/L |
|
Blood 血 | |
Blood Pressure 血壓 | N/A |
Body Height 身高 | N/A |
Body Mass Index (by Calculation) 體重指數 | N/A |
Body Weight 體重 | N/A |
Calcium 鈣,血清 | Conv. Units br>Female | ≥D1 : < Y1 | 8.5 - 11.0 mg/dL | ≥Y1 : < Y19 | 9.2 - 10.5 mg/dL | ≥Y19 : ≤ Y99 | 8.4 - 10.2 mg/dL | Male | ≥D1 : < Y1 | 8.5 - 11.0 mg/dL | ≥Y1 : < Y19 | 9.2 - 10.5 mg/dL | ≥Y19 : ≤ Y60 | 8.4 - 10.2 mg/dL | >Y60 : ≤ Y99 | 8.8 - 10.0 mg/dL | S.I. Units br>Female | ≥D1 : < Y1 | 2.13 - 2.75 mmol/L | ≥Y1 : < Y19 | 2.30 - 2.63 mmol/L | ≥Y19 : ≤ Y99 | 2.10 - 2.55 mmol/L | Male | ≥D1 : < Y1 | 2.13 - 2.75 mmol/L | ≥Y1 : < Y19 | 2.30 - 2.63 mmol/L | ≥Y19 : ≤ Y60 | 2.10 - 2.55 mmol/L | >Y60 : ≤ Y99 | 2.20 - 2.50 mmol/L |
|
Casts 圓柱體 | N/A |
CEA 癌胚抗原 | Conv. Units br>Healthy adults, non smokers | <5.0 ng/mL | Healthy adults, smokers | <5.0 ng/mL | Healthy adults upper limit | <10.0 ng/mL | S.I. Units br>Healthy adults, non smokers | <5.0 ug/L | Healthy adults, smokers | <5.0 ug/L | Healthy adults upper limit | <10.0 ug/L |
|
Chloride 氯化物 | Conv. Units br>≥d1 : ≤d31 | 98 - 113 mmol/L | ≥m1 : ≤y90 | 98 - 107 mmol/L | >y90 : ≤y99 | 98 - 111 mmol/L | S.I. Units br>≥d1 : ≤d31 | 98 - 113 mmol/L | ≥m1 : ≤y90 | 98 - 107 mmol/L | >y90 : ≤y99 | 98 - 111 mmol/L |
|
Cholesterol 總膽固醇 | Conv. Units br>Adult: | Desirable | < 200 mg/dL | Borderline high | 200 - 239 mg/dL | High | ≥ 240 mg/dL | | Child (< 19 Yr): | Desirable | < 170 mg/dL | S.I. Units br>Adult: | Desirable | < 5.18 mmol/L | Borderline high | 5.18 - 6.19 mmol/L | High | ≥ 6.20 mmol/L | | Child (< 19 Yr): | Desirable | < 4.4 mmol/L |
|
Color 顏色 | |
UMacro - Color 顏色 | N/A |
Consistency 稠性 | N/A |
hs CRP 高敏感C反應蛋白 | Conv. Units br>Cardiovascular Risk of Healthy Adults : | Low risk individual | < 0.10 mg/dL | Average | 0.10 - 0.30 mg/dL | High risk individual | > 0.30 - 1.00 mg/dL | Indeterminate | > 1.00 mg/dL | S.I. Units br>Cardiovascular Risk of Healthy Adults : | Low risk individual | < 1.0 mg/L | Average | 1.0 - 3.0 mg/L | High risk indvidual | > 3.0 - 10.0 mg/L | Indeterminate | > 10.0 mg/L |
|
Creatinine 肌酸酐 | Conv. Units br>Female | ≥D1 : < D15 | 0.32 - 0.92 mg/dL | ≥D15 : < Y2 | 0.10 - 0.36 mg/dL | ≥Y2 : < Y5 | 0.20 - 0.43 mg/dL | ≥Y5 : < Y12 | 0.31 - 0.61 mg/dL | ≥Y12 : < Y15 | 0.45 - 0.81 mg/dL | ≥Y15 : < Y19 | 0.49 - 0.84 mg/dL | ≥Y19 : ≤ Y99 | 0.55 - 1.02 mg/dL | Male | ≥D1 : < D15 | 0.32 - 0.92 mg/dL | ≥D15 : < Y2 | 0.10 - 0.36 mg/dL | ≥Y2 : < Y5 | 0.20 - 0.43 mg/dL | ≥Y5 : < Y12 | 0.31 - 0.61 mg/dL | ≥Y12 : < Y15 | 0.45 - 0.81 mg/dL | ≥Y15 : < Y19 | 0.62 - 1.08 mg/dL | ≥Y19 : ≤ Y99 | 0.73 - 1.18 mg/dL | S.I. Units br>Female | ≥D1 : < D15 | 28 - 81 umol/L | ≥D15 : < Y2 | 9 - 32 umol/L | ≥Y2 : < Y5 | 18 - 38 umol/L | ≥Y5 : < Y12 | 27 - 54 umol/L | ≥Y12 : < Y15 | 40 - 72 umol/L | ≥Y15 : < Y19 | 43 - 74 umol/L | ≥Y19 : ≤Y99 | 49 - 90 umol/L | Male | ≥D1 : < D15 | 28 - 81 umol/L | ≥D15 : < Y2 | 9 - 32 umol/L | ≥Y2 : < Y5 | 18 - 38 umol/L | ≥Y5 : < Y12 | 27 - 54 umol/L | ≥Y12 : < Y15 | 40 - 72 umol/L | ≥Y15 : < Y19 | 55- 95 umol/L | ≥Y19 : ≤ Y99 | 65 - 104 umol/L |
|
Crystals 結晶體 | N/A |
EBNA1, IgA 艾巴氏病毒抗體 | |
Eosinophils 嗜酸性細胞 | ≧D1 : < Y4 | | 0.0 - 8.3 % | ≧Y4 : < Y15 | | 1.0 - 13.0 % | ≧Y15 : < Y21 | | 0.3 - 6.7 % | ≧Y21 : ≦ Y150 | | 0.4 - 8.1 % |
|
Eosinophils 嗜酸性細胞 | ≧D1 : < Y1 | | 0.0 - 0.8 109/L | ≧Y1 : < Y13 | | 0.1 - 0.7 109/L | ≧Y13 : < Y21 | | 0.0 - 0.5 109/L | ≧Y21 : ≦ Y150 | | 0.0 - 0.5 109/L |
|
Epithelial cells 上皮細胞 | Male | Up to 5 cells/uL | Female | Up to 10 cells/uL |
|
ESR 血沉降率檢查 | Females ≦ 50 yrs | 0 - 20 mm/hr | Females > 50 yrs | 0 - 30 mm/hr | Males ≦ 50 yrs | 0 - 15 mm/hr | Males > 50 yrs | 0 - 20 mm/hr |
|
Gamma GT 丙種谷氨基轉移酵素 | Conv. Units br>Female | ≥D1 : < D15 | 23 - 219 U/L | ≥D15 : < Y1 | 8 - 127 U/L | ≥Y1 : < Y11 | 6 - 16 U/L | ≥Y11 : < Y19 | 7 - 21 U/L | ≥Y19 : ≤ Y99 | 0 - 38 U/L | Male | ≥D1 : < D15 | 23 - 219 U/L | ≥D15 : < Y1 | 8 - 127 U/L | ≥Y1 : < Y11 | 6 - 16 U/L | ≥Y11 : < Y19 | 7 - 21 U/L | ≥Y19 : ≤ Y99 | 0- 55 U/L | S.I. Units br>Female | ≥D1 : < D15 | 23 - 219 U/L | ≥D15 : < Y1 | 8 - 127 U/L | ≥Y1 : < Y11 | 6 - 16 U/L | ≥Y11 : < Y19 | 7 - 21 U/L | ≥Y19 : ≤ Y99 | 0 - 38 U/L | Male | ≥D1 : < D15 | 23 - 219 U/L | ≥D15 : < Y1 | 8 - 127 U/L | ≥Y1 : < Y11 | 6 - 16 U/L | ≥Y11 : < Y19 | 7 - 21 U/L | ≥Y19 : ≤ Y99 | 0- 55 U/L |
|
Globulin 球蛋白 | Conv. Units br>S.I. Units br> |
Glucose 糖 | |
Glucose 血葡萄糖 | Conv. Units br>Normal fasting glucose | 70-99 mg/dL | Impaired fasting glucose (IFG) | 100-125 mg/dL | Diabetes mellitus (DM), fasting glucose | ≥126 mg/dL | Diabetes mellitus (DM), random glucose | ≥200 mg/dL | S.I. Units br>Normal fasting glucose | 3.9-5.5 mmol/L | Impaired fasting glucose (IFG) | 5.6-6.9 mmol/L | Diabetes mellitus (DM), fasting glucose | ≥7.0 mmol/L | Diabetes mellitus (DM), random glucose | ≥11.1 mmol/L |
|
Haematocrit 紅血球壓積量 | Female | ≧D1 : < Y1 | | 27.6 - 38.8 % | ≧Y1 : < Y4 | | 31.0 - 38.8 % | ≧Y4 : < Y14 | | 34.3 - 42.6 % | ≧Y14 : < Y21 | | 35.3 - 45.4 % | ≧Y21 : ≦ Y150 | | 35.0 - 46.0 % | Male | ≧D1 : < Y1 | | 27.6 - 38.8 % | ≧Y1 : < Y4 | | 31.0 - 38.8 % | ≧Y4 : < Y14 | | 34.3 - 42.6 % | ≧Y14 : < Y21 | | 39.4 - 49.5 % | ≧Y21 : ≦ Y150 | | 40.0 - 51.0 % |
|
Haemoglobin 血紅蛋白 | Female | ≧D1 : < Y1 | | 9.3 - 12.9 g/dL | ≧Y1 : < Y4 | | 10.0 - 13.2 g/dL | ≧Y4 : < Y14 | | 11.2 - 14.1 g/dL | ≧Y14 : < Y21 | | 11.2 - 15.1 g/dL | ≧Y21 : ≦ Y150 | | 11.5 - 15.2 g/dL | Male | ≧D1 : < Y1 | | 9.3 - 12.9 g/dL | ≧Y1 : < Y4 | | 10.0 - 13.2 g/dL | ≧Y4 : < Y14 | | 11.2 - 14.1 g/dL | ≧Y14 : < Y21 | | 12.9 - 16.7 g/dL | ≧Y21 : ≦ Y150 | | 13.3 - 17.5 g/dL |
|
HbA1c 糖化血色素 | Reference intervals (NGSP): | Non-diabetic range (>18 years) | 4.0 - 6.0 % |  - Increased risk for future diabetes | 5.7 - 6.4 % |  - Diagnosing diabetes (at least 2 occasions) | ≧ 6.5 % | Diabetic adults >19 years old: |  - Goal of therapy | < 7.0 % |  - Action suggested | > 8.0 % | Average blood glucose level (eAG) correlated with HbA1c | A1c | eAG in past 8-12 weeks | 5 % | 97 mg/dL or 5.4 mmol/L | 6 % | 126 mg/dL or 7.0 mmol/L | 7 % | 154 mg/dL or 8.6 mmol/L | 8 % | 183 mg/dL or 10.2 mmol/L | 9 % | 212 mg/dL or 11.8 mmol/L | 10 % | 240 mg/dL or 13.4 mmol/L | 11 % | 269 mg/dL or 14.9 mmol/L | 12 % | 298 mg/dL or 16.5 mmol/L |
|
HDL Cholesterol 高密度脂蛋白膽固醇 | Conv. Units br>Low | < 40 mg/dL | High (Desirable) | > 60 mg/dL | S.I. Units br>Low | < 1.03 mmol/L | High (Desirable) | > 1.55 mmol/L |
|
Homocysteine 同型半胱胺酸 | Reference intervals:5 | Healthy adults | 5.0 - 15.9 umol/L | Moderately High | 16.0 - 30.0 umol/L | Intermediately High | 30.1 - 100 umol/L | Severely High | > 100 umol/L |
|
Ketones 酮體 | |
LDL Cholesterol, Direct 低密度脂蛋白膽固醇,直接 | Conv. Units br>Optimal | < 100 mg/dL | Near or above optimal | 100 - 129 mg/dL | Borderline high | 130 - 159 mg/dL | High | 160 - 189 mg/dL | Very High | ≥ 190 mg/dL | S.I. Units br>Optimal | < 2.59 mmol/L | Near or above optimal | 2.59 - 3.34 mmol/L | Borderline high | 3.35 - 4.11 mmol/L | High | 4.12 - 4.89 mmol/L | Very High | ≥ 4.90 mmol/L |
|
Lymphocytes 淋巴細胞 | ≧D1 : < Y1 | | 3.4 - 9.0 109/L | ≧Y1 : < Y5 | | 1.9 - 7.3 109/L | ≧Y5 : < Y15 | | 1.4 - 3.8 109/L | ≧Y15 : < Y21 | | 1.1 - 3.3 109/L | ≧Y21 : ≦ Y150 | | 1.1 - 3.2 109/L |
|
Lymphocytes 淋巴細胞 | ≧D1 : < Y1 | | 22.2 - 83.1 % | ≧Y1 : < Y5 | | 20.6 - 71.6 % | ≧Y5 : < Y15 | | 21.1 - 58.8 % | ≧Y15 : < Y21 | | 15.0 - 45.4 % | ≧Y21 : ≦ Y150 | | 18.6 - 48.7 % |
|
MCH 紅細胞平均血紅蛋白量 | ≧D1 : < Y1 | | 23.5 - 34.0 pg | ≧Y1 : < Y4 | | 23.5 - 28.2 pg | ≧Y4 : < Y14 | | 25.1 - 30.3 pg | ≧Y14 : < Y21 | | 25.6 - 32.0 pg | ≧Y21 : ≦ Y150 | | 27.0 - 33.7 pg |
|
MCHC 紅細胞平均血紅蛋白濃度 | ≧D1 : < Y1 | | 31.9 - 35.2 g/dL | ≧Y1 : < Y21 | | 31.0 - 34.5 g/dL | ≧Y21 : ≦ Y150 | | 31.6 - 35.4 g/dL |
|
CBC - MCV 平均紅血球容積 | Female | ≧D1 : < Y1 | | 72.0 - 98.6 fL | ≧Y1 : < Y4 | | 73.5 - 84.1 fL | ≧Y4 : < Y14 | | 77.4 - 92.1 fL | ≧Y14 : < Y20 | | 79.5 - 95.4 fL | ≧Y20 : ≦ Y150 | | 82.3 - 99.2 fL | Male | ≧D1 : < Y1 | | 72.0 - 98.6 fL | ≧Y1 : < Y4 | | 73.5 - 84.1 fL | ≧Y4 : < Y14 | | 77.6 - 91.0 fL | ≧Y14 : < Y20 | | 79.5 - 95.4 fL | ≧Y20 : ≦ Y150 | | 82.3 - 99.2 fL |
|
Monocytes 單核細胞 | Female | ≧D1 : < Y5 | | 5.1 - 12.6 % | ≧Y5 : < Y21 | | 4.3 - 12.1 % | ≧Y21 : ≦ Y150 | | 3.2 - 9.5 % | Male | ≧D1 : < Y5 | | 5.1 - 12.6 % | ≧Y5 : < Y21 | | 5.1 - 11.5 % | ≧Y21 : ≦ Y150 | | 3.2 - 9.5 % |
|
Monocytes 單核細胞 | ≧D1 : < Y1 | | 0.4 - 1.8 109/L | ≧Y1 : < Y5 | | 0.4 - 1.5 109/L | ≧Y5 : < Y21 | | 0.3 - 0.8 109/L | ≧Y21 : ≦ Y150 | | 0.2 - 0.6 109/L |
|
MPV 平均血小板容積 | Female | ≧D1 : < Y1 | | 8.6 - 11.3 fL | ≧Y1 : < Y4 | | 8.3 - 10.7 fL | ≧Y4 : < Y21 | | 9.0 - 12.8 fL | ≧Y21 : ≦ Y150 | | 7.7 - 12.0 fL | Male | ≧D1 : < Y1 | | 8.6 - 11.3 fL | ≧Y1 : < Y4 | | 8.3 - 10.7 fL | ≧Y4 : < Y21 | | 9.0 - 12.8 fL | ≧Y21 : ≦ Y150 | | 7.6 - 11.9 fL |
|
Neutrophils 中性粒細胞 | ≧D1 : < Y1 | | 8.7 - 57.9 % | ≧Y1 : < Y5 | | 18.6 - 68.6 % | ≧Y5 : < Y15 | | 28.9 - 67.9 % | ≧Y15 : < Y21 | | 39.6 - 73.9 % | ≧Y21 : ≦ Y150 | | 41.5 - 73.8 % |
|
Neutrophils 中性粒細胞 | ≧D1 : < Y1 | | 0.7 - 5.8 109/L | ≧Y1 : < Y21 | | 1.5 - 6.8 109/L | ≧Y21 : ≦ Y150 | | 1.8 - 6.3 109/L |
|
Nitrite 亞硝酸鹽 | |
Non HDL Cholesterol, by Calculation | N/A |
Occult Blood (FIT), Stool 糞便隱血 | Negative cutoff | < 100 ng/mL | Positive cutoff | ≧ 100 ng/mL |
|
Ova & Parasite 蟲卵及寄生蟲 | |
pH, Urine 尿液酸鹼度 | |
Phosphorus 磷, 血清 | Conv. Units br>Female | ≥D1 : < D15 | 5.6 - 10.5 mg/dL | ≥D15 : < Y1 | 4.8 - 8.4 mg/dL | ≥Y1 : < Y5 | 4.3 - 6.8 mg/dL | ≥Y5 : < Y13 | 4.1 - 5.9 mg/dL | ≥Y13 : < Y16 | 3.2 - 5.5 mg/dL | ≥Y16 : < Y19 | 2.9 - 5.0 mg/dL | ≥Y19 : ≤ Y99 | 2.5 - 4.5 mg/dL | Male | ≥D1 : < D15 | 5.6 - 10.5 mg/dL | ≥D15 : < Y1 | 4.8 - 8.4 mg/dL | ≥Y1 : < Y5 | 4.3 - 6.8 mg/dL | ≥Y5 : < Y13 | 4.1 - 5.9 mg/dL | ≥Y13 : < Y16 | 3.2 - 6.2 mg/dL | ≥Y16 : < Y19 | 2.9 - 5.0 mg/dL | ≥Y19 : ≤ Y99 | 2.5 - 4.5 mg/dL | S.I. Units br>Female | ≥D1 : < D15 | 1.81 - 3.39 mmol/L | ≥D15 : < Y1 | 1.55 - 2.71 mmol/L | ≥Y1 : < Y5 | 1.39 - 2.20 mmol/L | ≥Y5 : < Y13 | 1.32 - 1.91 mmol/L | ≥Y13 : < Y16 | 1.03 - 1.78 mmol/L | ≥Y16 : < Y19 | 0.94 - 1.62 mmol/L | ≥Y19 : ≤ Y99 | 0.81 - 1.45 mmol/L | Male | ≥D1 : < D15 | 1.81 - 3.39 mmol/L | ≥D15 : < Y1 | 1.55 - 2.71 mmol/L | ≥Y1 : < Y5 | 1.39 - 2.20 mmol/L | ≥Y5 : < Y13 | 1.32 - 1.91 mmol/L | ≥Y13 : < Y16 | 1.03 - 2.00 mmol/L | ≥Y16 : < Y19 | 0.94 - 1.62 mmol/L | ≥Y19 : ≤ Y99 | 0.81 - 1.45 mmol/L |
|
Platelet Count 血小板計數 | ≧D1 : < Y1 | | 253 - 552 109/L | ≧Y1 : < Y12 | | 203 - 431 109/L | ≧Y12 : < Y21 | | 173 - 361 109/L | ≧Y21 : ≦ Y150 | | 127 - 350 109/L |
|
Potassium 鉀, 血清 | Conv. Units br>≥d1 : ≤d31 | 3.4 - 6.0 mmol/L | ≥m1 : ≤y1 | 3.5 - 5.7 mmol/L | ≥y1 : ≤y16 | 3.5 - 5.0 mmol/L | >y16 : ≤y99 | 3.5 - 5.3 mmol/L | S.I. Units br>≥d1 : ≤d31 | 3.4 - 6.0 mmol/L | ≥m1 : ≤y1 | 3.5 - 5.7 mmol/L | ≥y1 : ≤y16 | 3.5 - 5.0 mmol/L | >y16 : ≤y99 | 3.5 - 5.3 mmol/L |
|
Protein 蛋白 | |
Protein, Total 總蛋白 | Conv. Units br>Female | ≥ D1 : < D15 | | 5.3 - 8.3 g/dL | ≥ D15 : < Y1 | | 4.4 - 7.1 g/dL | ≥ Y1 : < Y6 | | 6.1 - 7.5 g/dL | ≥ Y6 : < Y9 | | 6.4 - 7.7 g/dL | ≥ Y9 : < Y19 | | 6.5 - 8.1 g/dL | ≥ Y19 : ≤ Y60 | | 6.4 - 8.3 g/dL | > Y60 : ≤ Y99 | | 6.2 - 8.1 g/dL | Male | ≥ D1 : < D15 | | 5.3 - 8.3 g/dL | ≥ D15 : < Y1 | | 4.4 - 7.1 g/dL | ≥ Y1 : < Y6 | | 6.1 - 7.5 g/dL | ≥ Y6 : < Y9 | | 6.4 - 7.7 g/dL | ≥ Y9 : < Y19 | | 6.5 - 8.1 g/dL | ≥ Y19 : ≤ Y60 | | 6.4 - 8.3 g/dL | > Y60 : ≤ Y99 | | 6.2 - 8.1 g/dL | S.I. Units br>Female | ≥ D1 : < D15 | | 53 - 83 g/L | ≥ D15 : < Y1 | | 44 - 71 g/L | ≥ Y1 : < Y6 | | 61 - 75 g/L | ≥ Y6 : < Y9 | | 64 - 77 g/L | ≥ Y9 : < Y19 | | 65 - 81 g/L | ≥ Y19 : ≤ Y60 | | 64 - 83 g/L | > Y60 : ≤ Y99 | | 62 - 81 g/L | Male | ≥ D1 : < D15 | | 53 - 83 g/L | ≥ D15 : < Y1 | | 44 - 71 g/L | ≥ Y1 : < Y6 | | 61 - 75 g/L | ≥ Y6 : < Y9 | | 64 - 77 g/L | ≥ Y9 : < Y19 | | 65 - 81 g/L | ≥ Y19 : ≤ Y60 | | 64 - 83 g/L | > Y60 : ≤ Y99 | | 62 - 81 g/L |
|
PSA, Total 前列腺特殊抗原 | Conv. Units br>Healthy adults | | < 4.00 ng/mL | S.I. Units br>Healthy adults | | < 4.00 ug/L |
|
RBC 紅血球 | Male | Up to 10 cells/uL | Female | Up to 20 cells/uL |
|
RBC Count 紅血球計數 | Female | ≧D1 : < Y1 | | 3.05 - 4.85 1012/L | ≧Y1 : < Y4 | | 3.90 - 4.96 1012/L | ≧Y4 : < Y14 | | 3.95 - 5.00 1012/L | ≧Y14 : < Y21 | | 3.98 - 5.40 1012/L | ≧Y21 : ≦ Y150 | | 3.81 - 5.13 1012/L | Male | ≧D1 : < Y1 | | 3.00 - 5.18 1012/L | ≧Y1 : < Y4 | | 3.90 - 4.96 1012/L | ≧Y4 : < Y14 | | 4.14 - 5.14 1012/L | ≧Y14 : < Y21 | | 4.26 - 5.74 1012/L | ≧Y21 : ≦ Y150 | | 4.28 - 5.81 1012/L |
|
RDW 紅血球分佈比率 | Female | ≧D1 : < Y1 | | 12.0 - 17.0 % | ≧Y1 : < Y14 | | 11.5 - 14.5 % | ≧Y14 : < Y21 | | 11.5 - 15.6 % | ≧Y21 : ≦ Y150 | | 10.5 - 14.5 % | Male | ≧D1 : < Y1 | | 12.0 - 17.0 % | ≧Y1 : < Y14 | | 11.9 - 15.3 % | ≧Y14 : < Y21 | | 11.5 - 15.6 % | ≧Y21 : ≦ Y150 | | 10.5 - 14.5 % |
|
SGOT/AST 谷草轉氨酵素 | Conv. Units br>Female | ≥D1 : < D15 | 32 - 162 U/L | ≥D15 : < Y1 | 20 - 67 U/L | ≥Y1 : < Y7 | 21 - 44 U/L | ≥Y7 : < Y12 | 18 - 36 U/L | ≥Y12 : < Y19 | 13 - 26 U/L | ≥Y19 : ≤ Y99 | 11 - 34 U/L | Male | ≥D1 : < D15 | 32 - 162 U/L | ≥D15 : < Y1 | 20 - 67 U/L | ≥Y1 : < Y7 | 21 - 44 U/L | ≥Y7 : < Y12 | 18 - 36 U/L | ≥Y12 : < Y19 | 14 - 35 U/L | ≥Y19 : ≤ Y99 | 11 - 34 U/L | S.I. Units br>Female | ≥D1 : < D15 | 32 - 162 U/L | ≥D15 : < Y1 | 20 - 67 U/L | ≥Y1 : < Y7 | 21 - 44 U/L | ≥Y7 : < Y12 | 18 - 36 U/L | ≥Y12 : < Y19 | 13 - 26 U/L | ≥Y19 : ≤Y99 | 11 - 34 U/L | Male | ≥D1 : < D15 | 32 - 162 U/L | ≥D15 : < Y1 | 20 - 67 U/L | ≥Y1 : < Y7 | 21 - 44 U/L | ≥Y7 : < Y12 | 18 - 36 U/L | ≥Y12 : < Y19 | 14 - 35 U/L | ≥Y19 : ≤ Y99 | 11 - 34 U/L |
|
SGPT/ALT 谷丙轉氨酵素 | Conv. Units br>Female | ≥D1 : < Y1 | 5 - 33 U/L | ≥Y1 : < Y13 | 9 - 25 U/L | ≥Y13 : < Y19 | 8 - 22 U/L | ≥Y19 : ≤ Y99 | 0 - 34 U/L | Male | ≥D1 : < Y1 | 5 - 33 U/L | ≥Y1 : < Y13 | 9 - 25 U/L | ≥Y13 : < Y19 | 9 - 24 U/L | ≥Y19 : ≤ Y99 | 0 - 45 U/L | S.I. Units br>Female | ≥D1 : < Y1 | 5 - 33 U/L | ≥Y1 : < Y13 | 9 - 25 U/L | ≥Y13 : < Y19 | 8 - 22 U/L | ≥Y19 : ≤ Y99 | 0 - 34 U/L | Male | ≥D1 : < Y1 | 5 - 33 U/L | ≥Y1 : < Y13 | 9 - 25 U/L | ≥Y13 : < Y19 | 9 - 24 U/L | ≥Y19 : ≤ Y99 | 0 - 45 U/L |
|
Sodium 鈉, 血清 | Conv. Units br>≥ d1 : < d7 | 132 - 147 mmol/L | ≥ d7 : < y18 | 133 - 144 mmol/L | ≥ y18 : ≤ y99 | 135 - 145 mmol/L | S.I. Units br>≥ d1 : < d7 | 132 - 147 mmol/L | ≥ d7 : < y18 | 133 - 144 mmol/L | ≥ y18 : ≤ y99 | 135 - 145 mmol/L |
|
Specific Gravity 比重 | |
Triglycerides 三酸甘油脂 | Conv. Units br>Normal (Fasting) | < 150 mg/dL | Borderline High | 150 - 199 mg/dL | High | 200 - 499 mg/dL | Very High | ≥ 500 mg/dL | S.I. Units br>Normal (fasting) | < 1.70 mmol/L | Borderline high | 1.70 - 2.25 mmol/L | High | 2.26 - 5.64 mmol/L | Very High | ≥ 5.65 mmol/L |
|
TSH 促甲狀腺激素 | Conv. Units br>Euthyroid, non-pregnant | 0.35-2.82 uIU/mL | Thyroid insufficiency, mild | 3.00-5.00 uIU/mL | Thyroid insufficiency, slight | 5.10-10.00 uIU/mL | Hypothyroidism | >10.00 uIU/mL | Hyperthyroidism | <0.10 uIU/mL | Pregnancy | First trimester | 0.16-3.78 uIU/mL | Second trimester | 0.34-3.51 uIU/mL | Third trimester | 0.34-4.32 ulU/mL | Pediatric | <2 m | 1.10-6.30 ulU/mL | 2-<24 m | 0.90-4.90 ulU/mL | 2-<5 y | 0.80-4.40 ulU/mL | 5-<10 y | 0.80-4.10 ulU/mL | S.I. Units br>Euthyroid, non-pregnant | 0.35-2.82 mIU/L | Thyroid insufficiency, mild | 3.00-5.00 mIU/L | Thyroid insufficiency, slight | 5.10-10.00 mIU/L | Hypothyroidism | >10.00 mIU/L | Hyperthyroidism | <0.10 mIU/L | Pregnancy | First trimester | 0.16-3.78 mIU/L | Second trimester | 0.34-3.51 mIU/L | Third trimester | 0.34-4.32 mIU/L | Pediatric | <2 m | 1.10-6.30 mIU/L | 2-<24 m | 0.90-4.90 mIU/L | 2-<5 y | 0.80-4.40 mIU/L | 5-<10 y | 0.80-4.10 mIU/L |
|
Urea 尿素, 血清 | Conv. Units br>Female | ≥D1 : < D15 | 6 - 49 mg/dL | ≥D15 : < Y1 | 7 - 36 mg/dL | ≥Y1 : < Y10 | 19 - 47 mg/dL | ≥Y10 : < Y19 | 16 - 41 mg/dL | ≥Y19 : ≤ Y50 | 15 - 40 mg/dL | >Y50 : ≤ Y99 | 21 - 43 mg/dL | Male | ≥D1 : < D15 | 6 - 49 mg/dL | ≥D15 : < Y1 | 7 - 36 mg/dL | ≥Y1 : < Y10 | 19 - 47 mg/dL | ≥Y10 : < Y19 | 16 - 45 mg/dL | ≥Y19 : ≤ Y50 | 19 - 44 mg/dL | >Y50 : ≤ Y99 | 18 - 55 mg/dL | S.I. Units br>Female | ≥D1 : < D15 | 1.0 - 8.2 mmol/L | ≥D15 : < Y1 | 1.2 - 6.0 mmol/L | ≥Y1 : < Y10 | 3.2 - 7.9 mmol/L | ≥Y10 : < Y19 | 2.6 - 6.8 mmol/L | ≥Y19 : ≤ Y50 | 2.5 - 6.7 mmol/L | >Y50 : ≤ Y99 | 3.5 - 7.2 mmol/L | Male | ≥D1 : < D15 | 1.0 - 8.2 mmol/L | ≥D15 : < Y1 | 1.2 - 6.0 mmol/L | ≥Y1 : < Y10 | 3.2 - 7.9 mmol/L | ≥Y10 : < Y19 | 2.6 - 7.5 mmol/L | ≥Y19 : ≤ Y50 | 3.2 - 7.4 mmol/L | >Y50 : ≤ Y99 | 3.0 - 9.2 mmol/L |
|
Uric Acid 尿酸, 血清 | Conv. Units br>Female | ≥D1 : < D15 | 2.8 - 12.7 mg/dL | ≥D15 : < Y1 | 1.6 - 6.3 mg/dL | ≥Y1 : < Y12 | 1.8 - 4.9 mg/dL | ≥Y12 : < Y19 | 2.6 - 5.9 mg/dL | ≥Y19 : ≤Y99 | 2.5 - 6.2 mg/dL | Male | ≥D1 : < D15 | 2.8 - 12.7 mg/dL | ≥D15 : < Y1 | 1.6 - 6.3 mg/dL | ≥Y1 : < Y12 | 1.8 - 4.9 mg/dL | ≥Y12 : < Y19 | 2.6 - 7.6 mg/dL | ≥Y19 : ≤ Y99 | 3.7 - 7.7 mg/dL | S.I. Units br>Female | ≥D1 : < D15 | 0.17 - 0.75 mmol/L | ≥D15 : < Y1 | 0.09 - 0.37 mmol/L | ≥Y1 : < Y12 | 0.11 - 0.29 mmol/L | ≥Y12 : < Y19 | 0.15 - 0.35 mmol/L | ≥Y19 : ≤Y99 | 0.15 - 0.37 mmol/L | Male | ≥D1 : < D15 | 0.17 - 0.75 mmol/L | ≥D15 : < Y1 | 0.09 - 0.37 mmol/L | ≥Y1 : < Y12 | 0.11 - 0.29 mmol/L | ≥Y12 : < Y19 | 0.15 - 0.45 mmol/L | ≥Y19 : ≤ Y99 | 0.22 - 0.45 mmol/L |
|
Urobilinogen 尿膽原 | |
Vitamin D, Total 維生素D, 25-OH | Conv. Units br>Sufficiency | ≥ 30.0 ng/mL | Insufficiency | 20.0 - 29.9 ng/mL | Deficiency | < 20.0 ng/mL | Potentially toxic | > 100.0 ng/mL | S.I. Units br>Sufficiency | ≥ 75 nmol/L | Insufficiency | 50 - 75 nmol/L | Deficiency | < 50 nmol/L | Potentially toxic | > 250 nmol/L |
|
WBC 白血球 | Male | Up to 10 cells/uL | Female | Up to 15 cells/uL |
|
WBC Count 白血球計數 | ≧D1 : < Y3 | | 5.8 - 13.5 109/L | ≧Y3 : < Y5 | | 4.9 - 11.8 109/L | ≧Y5 : < Y21 | | 4.2 - 10.0 109/L | ≧Y21 : ≦ Y150 | | 3.7 - 9.4 109/L |
|
Yeast-like cells 類酵母菌 | N/A |